Sds Optic (WAR:SDS) Change In Receivables : zł0.13 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sds Optic Change In Receivables?

Sds Optic's change in receivables for the quarter that ended in Dec. 2024 was zł0.10 Mil. It means Sds Optic's Accounts Receivable declined by zł0.10 Mil from Sep. 2024 to Dec. 2024 .

Sds Optic's change in receivables for the fiscal year that ended in Dec. 2024 was zł0.15 Mil. It means Sds Optic's Accounts Receivable declined by zł0.15 Mil from Dec. 2023 to Dec. 2024 .

Sds Optic's Accounts Receivable for the quarter that ended in Dec. 2024 was zł0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sds Optic's liquidation value for the three months ended in Dec. 2024 was zł-8.36 Mil.

Sds Optic Change In Receivables Historical Data

The historical data trend for Sds Optic's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sds Optic Change In Receivables Chart

Sds Optic Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

0.73

-0.16

0.44

0.15

Sds Optic Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Receivables	Get a 7-Day Free Trial													-0.04	0.13	-0.09	-0.01	0.10

Sds Optic Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.13 Mil.

Sds Optic (WAR:SDS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sds Optic's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.003	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Sds Optic's accounts receivable are only considered to be worth 75% of book value:

Sds Optic's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5.555	-	13.915	+	0.75 * 0.003	+	0.5 * 0
=	-8.36

Sds Optic Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sds Optic's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Sds Optic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sds Optic SA (WAR:SDS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Gleboka 39, Centrum Ecotech-Complex, Block A, Lublin, POL, 20-612

Website

https://www.sdsoptic.pl

Sds Optic SA is engaged in developing and creating solutions on the borderline of biochemistry, engineering and fiber optic technologies, used in cancer diagnosis and treatment. The company has designed an Opto-biological methodology that allows for instant cellular processes studies including in-vivo cancer diagnosis with single-cell resolution. The company is also focused on manufacturing Optoelectronics.